Tolero Pharmaceuticals Inc., a medical technology company focused on developing treatments for hematological diseases, has opened its new headquarters in Lehi. Company officials, including CEO and founder David J. Bearss, joined state and local officials and a leadership team from the firm’s

Japanese parent company, Sumitomo Dainippon Pharma Co. Ltd., at a recent ribbon-cutting ceremony.

The rest of this article is only available to our online subscribers. Please log in, or click here to subscribe.

Pin It